200
Participants
Start Date
December 31, 2005
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
aripiprazole
Tablets, Oral, 5 mg, 10 mg, 15 mg, once daily, 16 weeks followed by 12 weeks of Open-Label extension phase (optional).
Placebo
Tablets, Oral, 0 mg, once daily, 16 weeks followed by 12 weeks of Open-Label extension phase (optional)
Local Institution, Graz
Local Institution, Innsbruck
Local Institution, Vienna
Local Institution, Brno - Bohunice
Local Institution, Hradec Králové
Local Institution, Litoměřice
Local Institution, Opava
Local Institution, Prague
Local Institution, Helsingin Kaupunki
Local Institution, Tampere
Local Institution, Turku
Local Institution, Brumath
Local Institution, Bully-les-Mines
Local Institution, Clermont-Ferrand
Local Institution, Limoges
Local Institution, Lyon
Local Institution, Nîmes
Local Institution, Paris
Local Institution, Rennex Cedex 7
Local Institution, Sotteville-lès-Rouen
Local Institution, Augsburg
Local Institution, Berlin
Local Institution, Duisburg
Local Institution, Haar
Local Institution, Heidelberg
Local Institution, Mannheim
Local Institution, Budapest
Local Institution, Szolnok
Local Institution, Krakow
Local Institution, Leszno
Local Institution, Skorzewo
Local Institution, Torun
Local Institution, Warsaw
Local Institution, Soweto
Local Institution, Vereeniging
Local Institution, Durban
Local Institution, Bellville
Local Institution, Cape Town
Local Institution, Bromma
Local Institution, Falköping
Local Institution, Linköping
Local Institution, Luleå
Local Institution, Malmo
Local Institution, Solna
Local Institution, Uppsala
Local Institution, Varberg
Local Institution, Västra Frölunda
Local Institution, Bern
Local Institution, Antalya
Local Institution, Istanbul
Local Institution, Izmir
Local Institution, Exeter
Local Institution, Teignmouth
Local Institution, Welwyn Garden City
Local Institution, Hull
Local Institution, Dundee
Local Institution, London
Collaborators (1)
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY